Announced
Completed
CD Capital led a $50m Series A-1 round in Neukio Biotherapeutics.
Synopsis
CD Capital led a $50m Series A-1 round in Neukio Biotherapeutics, a company committed to developing cell therapy products, with participation from Alwin Capital, Surplus Capital, Lilly Asia Ventures, Sherpa Healthcare Partners and IDG Capital.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.